Everyone Invests in Africa. Very Few Actually Deploy Capital. - A Thought Leadership Opinion by Anjo De Heus

The Africa Investment execution layer. A Thought Leadership opinion by Anjo De Heus


Everyone Invests in Africa. Very Few Actually Deploy Capital.

Why Africa’s real investment story begins after the LinkedIn posts end.

The Illusion of Abundance

Scroll LinkedIn on any given day and you could be forgiven for thinking Africa is awash with investors.

Every week, new “Africa-focused funds” emerge. Capital announcements circulate. Thought leadership flourishes. Everyone seems to be backing the continent’s next chapter.

And yet — on the ground — the same founders, operators, and governments are still asking the same question:

“Who actually writes the check?”

This disconnect is not accidental. It is structural.

Africa does not suffer from a shortage of interest. It suffers from a shortage of deployable, decision-ready capital.

The Hidden Math Behind “Africa Investment”

Let’s remove the clutter.

If you map the Africa-focused “investment” ecosystem visible on LinkedIn, you quickly discover three layers:

Layer 1: The Visible Layer (Very Large)

Thousands of profiles, companies, and platforms describe themselves as:

  • investors
  • funds
  • capital partners
  • global investment platforms
  • Africa growth vehicles

Most are not lying — but most are also not deploying capital.

They are:

  • advisory firms
  • ecosystem builders
  • accelerators
  • placement agents
  • policy platforms
  • networks and conveners

All valuable. All necessary.
But not execution capital.

Layer 2: The Semi-Deployers (Moderate)

This group includes:

  • early-stage funds with irregular closes
  • DFIs constrained by mandates and timelines
  • corporate venture arms with strategic, not financial, objectives
  • family offices that invest episodically

Capital here exists — but moves slowly, selectively, and often conditionally.

Deals happen, but friction is high.

Layer 3: The Execution Layer (Small, Quiet, Powerful)

This is where reality lives.

A comparatively small number of actors:

  • repeatedly deploy capital
  • have internal decision authority
  • understand regulatory and political terrain
  • can underwrite execution risk, not just pitch decks

They don’t post much.
They don’t brand loudly.
They are known by operators, not algorithms.

This layer is far smaller than LinkedIn suggests — and it explains why good projects still stall.

Why the Gap Exists

Africa is not “high risk” because of fundamentals alone.

It is high friction because:

  • capital structures are mismatched to execution timelines
  • decision rights are diffused across committees in other continents
  • investment mandates reward signaling, not deployment
  • local intelligence is often treated as an afterthought

The result?
A system optimized for announcements, not outcomes.

The Real Execution Question

For founders, governments, and operators, the question is no longer:

“Who is interested in Africa?”

It is:

“Who can decide, deploy, and stay?”

That single filter removes most of the noise instantly.

A More Honest Investment Vocabulary

If Africa’s investment ecosystem adopted clearer language, much confusion would disappear overnight.

Not everyone needs to be an “investor.”

Some are:

  • Capital Facilitators
  • Risk De-riskers
  • Ecosystem Builders
  • Market Architects
  • Execution Partners

These roles matter.
But pretending they are the same creates friction and false expectations.

Why This Is Actually Good News

Once you strip away the clutter, something encouraging appears:

  • The real execution layer is navigable
  • Capital does exist for credible, well-structured opportunities
  • Trust-based deployment still works in Africa
  • Long-term players are quietly scaling impact

Africa’s investment challenge is not one of belief.

It is one of precision.

The Next Phase Belongs to Executors

The next decade in Africa will not be led by those who speak the loudest about capital.

It will be shaped by those who:

  • understand structure
  • respect local power flows
  • align incentives before deploying funds
  • and stay long enough for outcomes to compound

When the noise fades, the real story begins.

And it is far more interesting than LinkedIn suggests.

Africa doesn’t need more investors on paper.
It needs more people willing to own execution.

Comments

Post a Comment

Popular posts from this blog

Launching a Healthtech Venture in the UAE: A Strategic Guide by 360Disruption

Image
A Strategic Launch Guide by @360disruption The United Arab Emirates (UAE) is quickly becoming one of the most promising launchpads for global healthtech innovation. With forward-thinking leadership, robust infrastructure, and a commitment to becoming a regional healthcare powerhouse, the UAE offers unparalleled opportunities for startups and scale-ups alike. At 360Disruption, we’ve helped companies from the U.S. and Europe navigate this ecosystem — and this guide captures what it takes to enter and scale across the Emirates. The Rise of Healthtech in the UAE: Why It Matters Across the UAE, government-driven healthcare modernization is accelerating. From Abu Dhabi’s academic health initiatives to Dubai’s smart health infrastructure , the country is positioning itself as a global healthtech hub. Key drivers include: Dubai Academic Health Corporation (DAHC) and Dubai Health Authority (DHA) initiatives such as NABIDH (Unified Medical Records) and Sheryan (Smart Licensing). Abu Dhabi...
Read more

Why 360Disruption Is the Partner of Choice for Health-tech Expansion in the Gulf

Image
In today’s competitive global health-tech landscape, entering new markets requires more than a regulatory checklist or a polished investor deck. It requires local traction, commercial validation, and trusted partnerships that can turn plans into performance. That’s where 360Disruption comes in. At 360Disruption, we don’t offer advisory in a vacuum. We execute. Whether you’re a U.S.-based company seeking to expand to the UAE, or a visionary startup looking for a trusted partner to bring your solution to life, we offer a pathway grounded in reality and built for scale Three Paths to Market Entry. One Strategic Engine. Every company we work with is different. Some are still testing product-market fit. Others are ready to scale. A few simply need the right on-the-ground team to carry the commercial flag. That’s why we built our platform around three adaptable tracks: 1. Incubation We work with early-stage companies or first-time entrants into the region to de-risk market entry, validate lo...
Read more

Why the UAE’s Medical Device Classification System is a Game-Changer for U.S. Healthtech Companies

Image
Why the UAE’s Medical Device Classification System is a Game-Changer for U.S. Healthtech Companies   The United Arab Emirates (UAE) has quietly built one of the world’s most innovation-friendly pathways for medical device companies—and now, more than ever, U.S.-based healthtech startups and scaleups should take notice. Unlike the FDA’s formal and risk-heavy classification system, the UAE’s Ministry of Health and Prevention (MOHAP) offers a flexible, product-specific, and internationally harmonized framework that accelerates market access, reduces cost, and creates entry into a health-conscious, tech-forward region. This is not just an alternative to the U.S. regulatory maze—it’s a springboard into the broader Middle East, Africa, and Asia.   UAE vs. FDA: Key Differences at a Glance Criteria FDA (USA) MOHAP / UAE Classification Class I, II, III Class I, IIa, IIb, III (EU MDR aligned) Approach Risk-based Risk-based + product-specific Timeline 12–36 months Weeks to classification...
Read more